<DOC>
	<DOCNO>NCT00361322</DOCNO>
	<brief_summary>The concept behind study combine effect antibiotic anti-inflammatory agent efficient acne therapy direct factor involve pathophysiology disease . For purpose evaluate combination clindamycin phosphate salicylic acid non-irritating carrier .</brief_summary>
	<brief_title>Efficacy Safety Preparation Containing Antibiotic Anti-Inflammatory Agent Acne Vulgaris</brief_title>
	<detailed_description />
	<mesh_term>Acne Vulgaris</mesh_term>
	<mesh_term>Clindamycin</mesh_term>
	<mesh_term>Clindamycin palmitate</mesh_term>
	<mesh_term>Clindamycin phosphate</mesh_term>
	<mesh_term>Salicylic Acid</mesh_term>
	<mesh_term>Salicylates</mesh_term>
	<mesh_term>Anti-Inflammatory Agents</mesh_term>
	<criteria>mild moderate acne vulgaris ; least 5 lesion face ; onemonth washout period establish topical systemic drug use treatment acne vulgaris . acne primarily truncal , nodular , due secondary causes/internal disease ; pregnancy , breastfeeding , intention become pregnant ; another dermatological disease face ; significant systemic disease ; drug/alcohol addiction ; interact medication ; know hypersensitivity study medication ; history chronic disease treat medication might affect acne condition treatment outcome ( e.g . corticosteroid , lithium , isoniazid , antiandrogens , phenytoin , phenobarbital ) precede month</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>45 Years</maximum_age>
	<verification_date>August 2006</verification_date>
</DOC>